We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
2301
People Inc
PPLI
$2.97B
| $406K | ﹤0.01% |
10,394
-5,574
| -35% | -$195K |
|
2302
Atea Pharmaceuticals
AVIR
$404M
| $405K | ﹤0.01% |
113,585
+26,525
| +30% | +$84.3K |
|
2303
Coca-Cola Europacific Partners
CCEP
$47.1B
| $405K | ﹤0.01% |
+4,449
| New | +$402K |
|
2304
CALL
Lucid Motors
LCID
$2.64B
| $404K | ﹤0.01% |
38,200
-1,300
| -3% | -$20.8K |
|
|
DBVT
2305
DBV Technologies
DBVT
$885M
| $402K | ﹤0.01% |
+20,961
| New | +$328K |
|
|
DMC
2306
Del Monte Corp
DMC
$1.45B
| $402K | ﹤0.01% |
+11,275
| New | +$402K |
|
2307
CALL
Wayfair
W
$14.1B
| $402K | ﹤0.01% |
4,000
+3,300
| +471% | +$317K |
|
2308
Flexible Solutions
FSI
$62.5M
| $401K | ﹤0.01% |
59,696
+7,679
| +15% | +$60.7K |
|
2309
Zurn Elkay Water Solutions
ZWS
$8.6B
| $401K | ﹤0.01% |
8,628
-2,700
| -24% | -$127K |
|
|
EMA
2310
Emera Inc
EMA
$15.7B
| $401K | ﹤0.01% |
+8,146
| New | +$394K |
|
|
LBRX
2311
LB Pharmaceuticals
LBRX
$1.3B
| $401K | ﹤0.01% |
18,014
-237,512
| -93% | -$4.15M |
|
2312
Vanguard Consumer Discretionary ETF
VCR
$6.15B
| $400K | ﹤0.01% |
1,016
-3,554
| -78% | -$1.39M |
|
2313
Pure Cycle
PCYO
$275M
| $400K | ﹤0.01% |
+36,381
| New | +$407K |
|
|
ARIS
2314
Aris Mining
ARIS
$3.58B
| $400K | ﹤0.01% |
24,632
-36,615
| -60% | -$450K |
|
2315
Grupo Cibest SA
CIB
$23.3B
| $398K | ﹤0.01% |
+6,261
| New | +$375K |
|
|
SAFE
2316
Safehold
SAFE
$1.08B
| $396K | ﹤0.01% |
+28,961
| New | +$412K |
|
2317
Atomera
ATOM
$217M
| $396K | ﹤0.01% |
+179,276
| New | +$542K |
|
|
MNTN
2318
MNTN Inc
MNTN
$843M
| $395K | ﹤0.01% |
+33,086
| New | +$477K |
|
2319
Neuronetics
STIM
$222M
| $395K | ﹤0.01% |
286,045
-639,065
| -69% | -$1.34M |
|
2320
Bel Fuse Inc Class A
BELFA
$3.38B
| $394K | ﹤0.01% |
2,597
-818
| -24% | -$110K |
|
2321
CPS Technologies
CPSH
$85.2M
| $393K | ﹤0.01% |
127,322
+84,799
| +199% | +$300K |
|
2322
Enterprise Financial Services Corp
EFSC
$2.4B
| $393K | ﹤0.01% |
7,277
+1,277
| +21% | +$70.1K |
|
|
JFIN
2323
Jiayin Group
JFIN
$125M
| $392K | ﹤0.01% |
+67,595
| New | +$569K |
|
|
BTQ
2324
BTQ Technologies Corp
BTQ
$638M
| $391K | ﹤0.01% |
+76,449
| New | +$580K |
|
2325
Allogene Therapeutics
ALLO
$732M
| $391K | ﹤0.01% |
+285,561
| New | +$377K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.